• / Free eNewsletters & Magazine
  • / My Account
Home>Research & Insights>Investment Insights>Performance Fees: An Idea Whose Time Has Come

Related Content

  1. Videos
  2. Articles
  1. PBMs: Health Care's Hidden Gems

    Pharmacy benefit managers aren't household names, but recent consolidation in the industry is proving out the power of scale for these firms, says Morningstar's Matt Coffina.

  2. Taking Another Look at Economic Moats

    Morningstar recently upgraded several companies' moat ratings, and global equity research director Heather Brilliant explains why.

  3. Express Scripts: A Good Risk/Reward Tradeoff

    Continued worries about Anthem's lawsuit have created a buying opportunity in the pharmacy benefit manager, says Morningstar's Matt Coffina.

  4. Be Sure to Understand Your Medicare Rules

    The Social Security Administration's Doug Nguyen and Andrew Salata clarify misconceived Medicare rules, including premiums, enrollment dates, differences from Social Security, and more.

Performance Fees: An Idea Whose Time Has Come

The current approach to levying fees is outmoded and in need of change.

Jeffrey Ptak, 08/17/2017

Executive Summary

> Funds typically levy fees as a fixed percentage of assets under management, but this approach seems outmoded and in need of change.

> Performance-based fees, which vary based on how well a fund performs versus a specified benchmark, could better align fund managers and shareholders.

> While there are arguments against using performance-based fees, they seem to flout market reality and pale when compared with the benefits such fees can yield.

> The forthcoming AB “FlexFee” funds, which would make significant fee adjustments based on fund performance, represent a welcome advance that’s worth watching.

An Outmoded System
U.S. mutual funds typically levy fees as a fixed percentage of assets. If you’re lucky, the board has negotiated some breakpoints with the manager that tier the fees lower as assets increase, but that’s usually as good as it gets. For all intents and purposes, investors are paying the same freight for as long as they own a fund, in sickness and in health.

This has meant investors in active funds have typically paid the same fee regardless of how well the funds have done. Crush the benchmark? That’ll be 1% please. Get annihilated? 1%. Perform in line? Well, you get the idea.

That approach seems outmoded and in need of change. Investors are heading in droves to passive funds in large part because they want a fairer shake—that is, to pay fees commensurate with the value they feel they’re receiving. By this standard, active funds aren’t cutting it. And why? Because they charge a premium for a value-add that often fails to materialize.

Guest Author

©2017 Morningstar Advisor. All right reserved.